| Name | Title | Contact Details |
|---|
ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III
Alego Health is a Eastlake, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Thibodaux Regional Medical Center is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Thibodaux Regional Medical Center is based in Thibodaux, LA. You can find more information on Thibodaux Regional Medical Center at www.thibodaux.com
National Stroke Association is a Englewood, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
HMS® (NASDAQ: HMSY) advances the healthcare system by helping healthcare organizations reduce costs and improve health outcomes. Through our industry-leading technology, analytics and engagement solutions, we save billions of healthcare dollars annually while helping consumers lead healthier lives. HMS provides a broad range of coordination of benefits, payment integrity and population health management solutions that help move the healthcare system forward.